Filing Details

Accession Number:
0001367644-20-000145
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-09-04 20:08:20
Reporting Period:
2020-09-02
Accepted Time:
2020-09-04 20:08:20
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1367644 Emergent Biosolutions Inc. EBS () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1193522 W Louis Sullivan 400 Professional Dr, Suite 400
Gaithersburg MD 20879
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-09-02 20,525 $111.22 42,762 No 4 S Direct
Common Stock Acquisiton 2020-09-02 7,893 $20.08 50,655 No 4 M Direct
Common Stock Disposition 2020-09-02 7,893 $111.23 42,762 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Options (Right to Buy) Acquisiton 2020-09-02 7,893 $0.00 7,893 $20.08
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
15,786 2021-05-19 No 4 M Direct
Footnotes
  1. Consists of previously exercised options granted under the company's stock incentive plan as amended and restated.
  2. The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices between $110.96 and $111.40.
  3. Consists of an option granted under the company's stock incentive plan as amended and restated.
  4. The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices between $110.96 and $111.32.
  5. The option grant is fully vested.